{"meta":{"status":200,"messages":[],"pagination":{"max":1,"offset":0,"count":1,"total":1,"pageNum":1,"totalPages":1,"sort":null,"currentUrl":"https://api.digitalmedia.hhs.gov/api/v2/resources/media.json?offset=0&max=1&ignoreHiddenMedia=1&format=json&id=6507&newUrlBase=http://www.cdc.gov/yellowfever/links","nextUrl":null,"previousUrl":null}},"results":[{"content":"
\nBarwick R. History of thymoma and yellow fever vaccination. Lancet. 2004;364(9438):936.
\nCavalcanti DP, Salomao MA, Lopez-Camelo J, et al. Early exposure to yellow fever vaccine during pregnancy. Trop Med Int Health. 2007;12(7):833\u20137.
\nCDC. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(RR-7):1\u201327.
\nCDC. Yellow fever vaccine booster doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(23):647\u201350.
\nCDC. Notes from the Field: Fatal Yellow Fever Vaccine\u2013Associated Viscerotropic Disease \u2014 Oregon, September 2014. MMWR Morb Mortal Wkly Rep. 2015;64(10):279\u2013281.
\nGershman MD, Staples JE, Bentsi-Enchill AD, Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2012;30(33):5038\u201358.
\nHayes EB. Acute viscerotropic disease following vaccination against yellow fever. Trans R Soc Trop Med Hyg. 2007;101(10):967\u201371.
\nJentes ES. Poumerol G, Gershman MD, et al. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infect Dis. 2011;11:622-32.
\nLindsey NP, Schroeder BA, Miller ER, et al. Adverse event reports following yellow fever vaccination. Vaccine. 2008;26(48):6077\u201382.
\nMcMahon AW, Eidex RB, Marfin AA, et al. Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. Vaccine. 2007;25(10):1727\u201334.
\nMonath TP, Cetron MS. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis. 2002;34(10):1369\u201378.
\nMonath TP, Gershman M, Staples JE, Barrett ADT. Yellow fever vaccine. In: Plotkin S, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia: Elsevier Saunders; 2013. p. 870\u2013968.
\nMu\u00f1oz J, Vilella A, Domingo C, et al. Yellow fever-associated viscerotropic disease in Barcelona, Spain. J Travel Med. 2008;15(3):202\u20135.
\nNasidi A, Monath TP, Vandenberg J, et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg. 1993;87(3):337\u20139.
\nNishioka Sde A, Nunes-Araujo FRF, Pires WP, et al. Yellow fever vaccination during pregnancy and spontaneous abortion: a case\u2013control study. Trop Med Int Health. 1998;3(1):29\u201333.
\nSuzano CE, Amaral E, Sato HK, et al. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil. Vaccine. 2006;24(9):1421\u20136.
\nWorld Health Organization. Vaccines and vaccination against yellow fever. WHO position paper \u2014 June 2013. Wkly Epidemiol Rec. 2013;88(27):269\u201383.
\n \n